Global Rofecoxib Professional Survey Report

Global Rofecoxib Professional Survey Report 2024, Forecast to 2029

Global Rofecoxib Professional Survey Report

Global Rofecoxib Professional Survey Report 2024, Forecast to 2029


Analysis of the Rofecoxib Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Rofecoxib was a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.

Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.

We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.

Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.

The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.

The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.

We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.

The report will conduct a comprehensive and professional analysis of the Rofecoxib market in 2024 based on the current situation, global economic impact and other aspects.

Market Segment by Product Type

Oral Suspension.

Tablet-Form

Market Segment by Product Application

Osteoarthritis

Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis

Acute Pain Conditions

Migraine

Dysmenorrhea

Finally, the report provides detailed profile and data information analysis of leading company.

Merck

Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD

Chengdu Meinkai Chemical Co. LTD

Wuhan Xinxin Jiali Biotechnology Co. LTD

Tremeau

Pfizer

Insights and Tools:

This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.

The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.

Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.

The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.

Research Objectives

1.To define, describe and forecast the Rofecoxib market by type, application, end user and region

2.Provide enterprise external environment analysis and SWOT analysis

3.Focuses on the key global Rofecoxib manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.

4.Provide market entry strategy analysis for new players or players preparing to enter the market

5.Keep up with international market trends and analyze the impact of the important international events on major global regions

6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape

Global Rofecoxib Professional Survey Report Report 2024, Forecast to 2029

1 Market Study Overview

1.1 Study Objectives

1.2 Rofecoxib Introduce

1.3 Combined with the Analysis of Macroeconomic Indicators

1.4 Brief Description of Research Methods

1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary

2.1 Rofecoxib Segment by Type

2.1.1 Oral Suspension.

2.1.2 Tablet-Form

2.2 Market Analysis by Application

2.2.1 Osteoarthritis

2.2.2 Rheumatoid Arthritis

2.2.3 Juvenile Rheumatoid Arthritis

2.2.4 Acute Pain Conditions

2.2.5 Migraine

2.2.6 Dysmenorrhea

2.3 Global Rofecoxib Market Comparison by Regions (2019-2029)

2.3.1 Global Rofecoxib Market Size (2019-2029)

2.3.2 North America Rofecoxib Status and Prospect (2019-2029)

2.3.3 Europe Rofecoxib Status and Prospect (2019-2029)

2.3.4 Asia-pacific Rofecoxib Status and Prospect (2019-2029)

2.3.5 South America Rofecoxib Status and Prospect (2019-2029)

2.3.6 Middle East & Africa Rofecoxib Status and Prospect (2019-2029)

2.4 Basic Product Information

2.4.1 Basic Product Information & Technology Development History

2.4.2 Product Manufacturing Process

2.4.3 Interview with Major Market Participants

2.4.4 High-end Market Analysis and Forecast

2.5 Coronavirus Disease 2020 (Covid-19): Rofecoxib Industry Impact

2.5.1 Rofecoxib Business Impact Assessment - Covid-19

2.5.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape

2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer

3.1 Global Rofecoxib Sales and Market Share by Manufacturer (2019-2024)

3.2 Global Rofecoxib Revenue and Market Share by Manufacturer (2019-2024)

3.3 Global Rofecoxib Industry Concentration Ratio (CR5 and HHI)

3.4 Top 5 Rofecoxib Manufacturer Market Share

3.5 Top 10 Rofecoxib Manufacturer Market Share

3.6 Date of Key Manufacturers Enter into Rofecoxib Market

3.7 Key Manufacturers Rofecoxib Product Offered

3.8 Mergers & Acquisitions Planning

4 Analysis of Rofecoxib Industry Key Manufacturers

4.1 Merck

4.1.1 Company Details

4.1.2 Merck Rofecoxib Product Introduction, Application and Specification

4.1.3 Merck Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.1.4 Main Business Overview

4.1.5 Merck News

4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD

4.2.1 Company Details

4.2.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification

4.2.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.2.4 Main Business Overview

4.2.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD News

4.3 Chengdu Meinkai Chemical Co. LTD

4.3.1 Company Details

4.3.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification

4.3.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.3.4 Main Business Overview

4.3.5 Chengdu Meinkai Chemical Co. LTD News

4.4 Wuhan Xinxin Jiali Biotechnology Co. LTD

4.4.1 Company Details

4.4.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Introduction, Application and Specification

4.4.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.4.4 Main Business Overview

4.4.5 Wuhan Xinxin Jiali Biotechnology Co. LTD News

4.5 Tremeau

4.5.1 Company Details

4.5.2 Tremeau Rofecoxib Product Introduction, Application and Specification

4.5.3 Tremeau Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.5.4 Main Business Overview

4.5.5 Tremeau News

4.6 Pfizer

4.6.1 Company Details

4.6.2 Pfizer Rofecoxib Product Introduction, Application and Specification

4.6.3 Pfizer Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)

4.6.4 Main Business Overview

4.6.5 Pfizer News

5 Global Rofecoxib Sales Categorized by Regions

5.1 Global Rofecoxib Revenue, Sales and Market Share by Regions

5.1.1 Global Rofecoxib Sales and Market Share by Regions (2019-2024)

5.1.2 Global Rofecoxib Revenue and Market Share by Regions (2019-2024)

5.2 North America Rofecoxib Sales and Growth Rate (2019-2024)

5.3 Europe Rofecoxib Sales and Growth Rate (2019-2024)

5.4 Asia-pacific Rofecoxib Sales and Growth Rate (2019-2024)

5.5 South America Rofecoxib Sales and Growth Rate (2019-2024)

5.6 Middle East & Africa Rofecoxib Sales and Growth Rate (2019-2024)

6 North America Rofecoxib Market Size Categorized by Countries

6.1 North America Rofecoxib Sales, Revenue and Market Share by Countries

6.1.1 North America Rofecoxib Sales (Volume) by Countries (2019-2024)

6.1.2 North America Rofecoxib Revenue by Countries (2019-2024)

6.1.3 United States Rofecoxib Sales and Growth Rate (2019-2024)

6.1.4 Canada Rofecoxib Sales and Growth Rate (2019-2024)

6.1.5 Mexico Rofecoxib Sales and Growth Rate (2019-2024)

6.2 North America Rofecoxib Revenue (Value) by Manufacturers

6.3 North America Rofecoxib Sales and Market Share by Type (2019-2024)

6.4 North America Rofecoxib Sales Market Share by Application (2019-2024)

7 Europe Rofecoxib Market Size Categorized by Countries

7.1 Europe Rofecoxib Sales, Revenue and Market Share by Countries

7.1.1 Europe Rofecoxib Sales (Volume) by Countries (2019-2024)

7.1.2 Europe Rofecoxib Revenue by Countries (2019-2024)

7.1.3 Germany Rofecoxib Sales and Growth Rate (2019-2024)

7.1.4 UK Rofecoxib Sales and Growth Rate (2019-2024)

7.1.5 France Rofecoxib Sales and Growth Rate (2019-2024)

7.1.6 Russia Rofecoxib Sales and Growth Rate (2019-2024)

7.1.7 Italy Rofecoxib Sales and Growth Rate (2019-2024)

7.1.8 Spain Rofecoxib Sales and Growth Rate (2019-2024)

7.2 Europe Rofecoxib Revenue (Value) by Manufacturers

7.3 Europe Rofecoxib Sales and Market Share by Type (2019-2024)

7.4 Europe Rofecoxib Sales Market Share by Application (2019-2024)

8 Asia-Pacific Rofecoxib Market Size Categorized by Countries

8.1 Asia-pacific Rofecoxib Sales, Revenue and Market Share by Countries

8.1.1 Asia-pacific Rofecoxib Sales (Volume) by Countries (2019-2024)

8.1.2 Asia-pacific Rofecoxib Revenue by Countries (2019-2024)

8.1.3 China Rofecoxib Sales and Growth Rate (2019-2024)

8.1.4 South Korea Rofecoxib Sales and Growth Rate (2019-2024)

8.1.5 Japan Rofecoxib Sales and Growth Rate (2019-2024)

8.1.6 Australia Rofecoxib Sales and Growth Rate (2019-2024)

8.1.7 India Rofecoxib Sales and Growth Rate (2019-2024)

8.1.8 Southeast Asia Rofecoxib Sales and Growth Rate (2019-2024)

8.2 Asia-pacific Rofecoxib Revenue (Value) by Manufacturers

8.3 Asia-pacific Rofecoxib Sales and Market Share by Type (2019-2024)

8.4 Asia-pacific Rofecoxib Sales Market Share by Application (2019-2024)

9 South America Rofecoxib Market Size Categorized by Countries

9.1 South America Rofecoxib Sales, Revenue and Market Share by Countries

9.1.1 South America Rofecoxib Sales (Volume) by Countries (2019-2024)

9.1.2 South America Rofecoxib Revenue by Countries (2019-2024)

9.1.3 Brazil Rofecoxib Sales and Growth Rate (2019-2024)

9.2 South America Rofecoxib Sales and Market Share by Type (2019-2024)

9.3 South America Rofecoxib Sales Market Share by Application (2019-2024)

10 Middle East and Africa Rofecoxib Market Size Categorized by Countries

10.1 Middle East and Africa Rofecoxib Sales, Revenue and Market Share by Countries

10.1.1 Middle East and Africa Rofecoxib Sales (Volume) by Countries (2019-2024)

10.1.2 Middle East and Africa Rofecoxib Revenue by Countries (2019-2024)

10.1.3 GCC Countries Rofecoxib Sales and Growth Rate (2019-2024)

10.1.4 Turkey Rofecoxib Sales and Growth Rate (2019-2024)

10.1.5 Egypt Rofecoxib Sales and Growth Rate (2019-2024)

10.1.6 South America Rofecoxib Sales and Growth Rate (2019-2024)

10.2 Middle East and Africa Rofecoxib Sales and Market Share by Type

10.3 Middle East and Africa Rofecoxib Sales Market Share by Application (2019-2024)

11 Global Rofecoxib Market Segment by Type

11.1 Global Rofecoxib Revenue, Sales and Market Share by Type (2019-2024)

11.1.1 Global Rofecoxib Sales and Market Share by Type (2019-2024)

11.1.2 Global Rofecoxib Revenue and Market Share by Type (2019-2024)

11.2 Oral Suspension. Sales Growth Rate and Price

11.2.1 Global Oral Suspension. Sales Growth Rate (2019-2024)

11.2.2 Global Oral Suspension. Price (2019-2024)

11.3 Tablet-Form Sales Growth Rate and Price

11.3.1 Global Tablet-Form Sales Growth Rate (2019-2024)

11.3.2 Global Tablet-Form Price (2019-2024)

12 Global Rofecoxib Market Segment by Application

12.1 Global Rofecoxib Sales Market Share by Application (2019-2024)

12.2 Osteoarthritis Sales Growth Rate (2019-2024)

12.3 Rheumatoid Arthritis Sales Growth Rate (2019-2024)

12.4 Juvenile Rheumatoid Arthritis Sales Growth Rate (2019-2024)

12.5 Acute Pain Conditions Sales Growth Rate (2019-2024)

12.7 Dysmenorrhea Sales Growth Rate (2019-2024)

13 Global Rofecoxib Market Forecast

13.1 Global Rofecoxib Revenue, Sales and Growth Rate (2024-2029)

13.2 Rofecoxib Market Forecast by Regions (2024-2029)

13.2.1 North America Rofecoxib Market Forecast (2024-2029)

13.2.2 Europe Rofecoxib Market Forecast (2024-2029)

13.2.3 Asia-Pacific Rofecoxib Market Forecast (2024-2029)

13.2.4 South America Rofecoxib Market Forecast (2024-2029)

13.2.5 Middle East & Africa Rofecoxib Market Forecast (2024-2029)

13.3 Rofecoxib Market Forecast by Type (2024-2029)

13.3.1 Global Rofecoxib Sales Forecast by Type (2024-2029)

13.3.2 Global Rofecoxib Market Share Forecast by Type (2024-2029)

13.4 Rofecoxib Market Forecast by Application (2024-2029)

13.4.1 Global Rofecoxib Sales Forecast by Application (2024-2029)

13.4.2 Global Rofecoxib Market Share Forecast by Application (2024-2029)

14 Market Analysis

14.1.1 Market overview

14.1.2 Market Opportunities

14.1.3 Market Risk

14.1.4 Market Driving Force

14.1.5 Porter's Five Forces Analysis

14.1.6 SWOT Analysis

15 Rofecoxib Industry Related Market Analysis

15.1 Upstream Analysis

15.1.1 Macro Analysis of Upstream Markets

15.1.2 Key Players in Upstream Markets

15.1.3 Upstream Market Trend Analysis

15.1.4 Rofecoxib Manufacturing Cost Analysis

15.2 Downstream Market Analysis

15.2.1 Macro Analysis of Down Markets

15.2.2 Key Players in Down Markets

15.2.3 Downstream Market Trend Analysis

15.2.4 Sales Channel, Distributors, Traders and Dealers

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Rofecoxib Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Rofecoxib Market trending toward high growth trajectories?
A dynamic process in the Rofecoxib Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Merck, Pfizer, Novartis, Roche, GlaxoSmithKline, Bayer, Sanofi, Johnson & Johnson, AstraZeneca, Takeda Pharmaceuticals, Teva Pharmaceuticals, Mylan, Sun Pharmaceuticals, Dr. Reddy’s, Lupin, Cipla, Apotex, Zydus Cadila, Glenmark, Torrent Pharmaceuticals.
What is the Rofecoxib Market really preparing for?
Companies in the Rofecoxib Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
Who are the significant end-users in the Rofecoxib Market?
The key end-users in the Rofecoxib Market are Pain Relief, Arthritis, Osteoarthritis, Post-Surgical Recovery
What is the current state of the Rofecoxib Industry, and what is the projected growth trajectory through 2030?
In 2024, the Rofecoxib Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
Where does the Rofecoxib Industry stands in terms of scaling end-use implementations?
According to the Rofecoxib Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
What is the estimated global market value of the Rofecoxib Market?
The Rofecoxib Market is expected to reach a considerable market valuation.